A Conformational Intermediate in Glutamate Receptor Activation
Ionotropic glutamate receptors (iGluRs) transduce the chemical signal of neurotransmitter release into membrane depolarization at excitatory synapses in the brain. The opening of the transmembrane ion channel of these ligand-gated receptors is driven by conformational transitions that are induced by...
Gespeichert in:
Veröffentlicht in: | Neuron (Cambridge, Mass.) Mass.), 2013-08, Vol.79 (3), p.492-503 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 503 |
---|---|
container_issue | 3 |
container_start_page | 492 |
container_title | Neuron (Cambridge, Mass.) |
container_volume | 79 |
creator | Lau, Albert Y. Salazar, Héctor Blachowicz, Lydia Ghisi, Valentina Plested, Andrew J.R. Roux, Benoît |
description | Ionotropic glutamate receptors (iGluRs) transduce the chemical signal of neurotransmitter release into membrane depolarization at excitatory synapses in the brain. The opening of the transmembrane ion channel of these ligand-gated receptors is driven by conformational transitions that are induced by the association of glutamate molecules to the ligand-binding domains (LBDs). Here, we describe the crystal structure of a GluA2 LBD tetramer in a configuration that involves an ∼30° rotation of the LBD dimers relative to the crystal structure of the full-length receptor. The configuration is stabilized by an engineered disulfide crosslink. Biochemical and electrophysiological studies on full-length receptors incorporating either this crosslink or an engineered metal bridge show that this LBD configuration corresponds to an intermediate state of receptor activation. GluA2 activation therefore involves a combination of both intra-LBD (cleft closure) and inter-LBD dimer conformational transitions. Overall, these results provide a comprehensive structural characterization of an iGluR intermediate state.
•The crystal structure of a GluA2 LBD tetramer captures an activation intermediate•Glutamate-binding domain dimers rotate by ?30° during activation•A disulfide bond between subunits traps a partially activated state•Trapping by engineered metal bridges confirms the conformational arrangement
Lau et al. show that an intermediate state in the activation pathway of AMPARs, a class of ionotropic glutamate receptors, involves an ∼30° rotation between the two ligand-binding domain dimers. |
doi_str_mv | 10.1016/j.neuron.2013.06.003 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3814226</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0896627313004947</els_id><sourcerecordid>1560110160</sourcerecordid><originalsourceid>FETCH-LOGICAL-c524t-80d1fbd68ee2988d5ce0ba767df1c332e81acc82af8d53abaa1b1abc2b373b453</originalsourceid><addsrcrecordid>eNp9kU9r3DAQxUVJabZpv0EJhlx6sauRbFm-BJYlTQOBQmnPQpbHiRZb2kjyQr59tN00_XPoSQzzm6c38wj5ALQCCuLTtnK4BO8qRoFXVFSU8ldkBbRryxq67oSsqOxEKVjLT8nbGLeUQt108IacMt7xjMgVuVwXG-9GH2adrHd6Km5cwjDjYHXCwrrielqSng_FNzS4Sz4Ua5Ps_if_jrwe9RTx_fN7Rn58vvq--VLefr2-2axvS9OwOpWSDjD2g5CIrJNyaAzSXreiHUYwnDOUoI2RTI-5x3WvNfSge8N63vK-bvgZuTzq7pY-ezPoUtCT2gU76_CovLbq746z9-rO7xWXUDMmssDHZ4HgHxaMSc02Gpwm7dAvUUEjKBzuSjN68Q-69UvIp8mUyF5qWXOWqfpImeBjDDi-mAGqDkJqq44BqUNAigqVA8pj538u8jL0K5Hfm2I-595iUNFYdCYHEtAkNXj7_x-eAGMapQ8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1645348432</pqid></control><display><type>article</type><title>A Conformational Intermediate in Glutamate Receptor Activation</title><source>MEDLINE</source><source>Cell Press Free Archives</source><source>Elsevier ScienceDirect Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Lau, Albert Y. ; Salazar, Héctor ; Blachowicz, Lydia ; Ghisi, Valentina ; Plested, Andrew J.R. ; Roux, Benoît</creator><creatorcontrib>Lau, Albert Y. ; Salazar, Héctor ; Blachowicz, Lydia ; Ghisi, Valentina ; Plested, Andrew J.R. ; Roux, Benoît</creatorcontrib><description>Ionotropic glutamate receptors (iGluRs) transduce the chemical signal of neurotransmitter release into membrane depolarization at excitatory synapses in the brain. The opening of the transmembrane ion channel of these ligand-gated receptors is driven by conformational transitions that are induced by the association of glutamate molecules to the ligand-binding domains (LBDs). Here, we describe the crystal structure of a GluA2 LBD tetramer in a configuration that involves an ∼30° rotation of the LBD dimers relative to the crystal structure of the full-length receptor. The configuration is stabilized by an engineered disulfide crosslink. Biochemical and electrophysiological studies on full-length receptors incorporating either this crosslink or an engineered metal bridge show that this LBD configuration corresponds to an intermediate state of receptor activation. GluA2 activation therefore involves a combination of both intra-LBD (cleft closure) and inter-LBD dimer conformational transitions. Overall, these results provide a comprehensive structural characterization of an iGluR intermediate state.
•The crystal structure of a GluA2 LBD tetramer captures an activation intermediate•Glutamate-binding domain dimers rotate by ?30° during activation•A disulfide bond between subunits traps a partially activated state•Trapping by engineered metal bridges confirms the conformational arrangement
Lau et al. show that an intermediate state in the activation pathway of AMPARs, a class of ionotropic glutamate receptors, involves an ∼30° rotation between the two ligand-binding domain dimers.</description><identifier>ISSN: 0896-6273</identifier><identifier>EISSN: 1097-4199</identifier><identifier>DOI: 10.1016/j.neuron.2013.06.003</identifier><identifier>PMID: 23931998</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Benzothiadiazines - pharmacology ; Biophysical Phenomena - drug effects ; Biophysical Phenomena - genetics ; Cell Line, Transformed ; Chemical bonds ; Crystal structure ; Crystallography, X-Ray - methods ; Cysteine - genetics ; Dithionitrobenzoic Acid - pharmacology ; Dose-Response Relationship, Drug ; Electric Stimulation ; Excitatory Amino Acid Antagonists - pharmacology ; Glutamic Acid - pharmacology ; Humans ; In Vitro Techniques ; Ligands ; Membrane Potentials - drug effects ; Membrane Potentials - genetics ; Models, Molecular ; Molecular Conformation ; Mutation ; Mutation - genetics ; Patch-Clamp Techniques ; Phenanthrolines - pharmacology ; Protein Structure, Tertiary - genetics ; Proteins ; Quinoxalines - pharmacology ; Receptors, Glutamate - chemistry ; Receptors, Glutamate - genetics ; Receptors, Glutamate - metabolism ; Uncoupling Agents - pharmacology</subject><ispartof>Neuron (Cambridge, Mass.), 2013-08, Vol.79 (3), p.492-503</ispartof><rights>2013 Elsevier Inc.</rights><rights>Copyright © 2013 Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Limited Aug 7, 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c524t-80d1fbd68ee2988d5ce0ba767df1c332e81acc82af8d53abaa1b1abc2b373b453</citedby><cites>FETCH-LOGICAL-c524t-80d1fbd68ee2988d5ce0ba767df1c332e81acc82af8d53abaa1b1abc2b373b453</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0896627313004947$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23931998$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lau, Albert Y.</creatorcontrib><creatorcontrib>Salazar, Héctor</creatorcontrib><creatorcontrib>Blachowicz, Lydia</creatorcontrib><creatorcontrib>Ghisi, Valentina</creatorcontrib><creatorcontrib>Plested, Andrew J.R.</creatorcontrib><creatorcontrib>Roux, Benoît</creatorcontrib><title>A Conformational Intermediate in Glutamate Receptor Activation</title><title>Neuron (Cambridge, Mass.)</title><addtitle>Neuron</addtitle><description>Ionotropic glutamate receptors (iGluRs) transduce the chemical signal of neurotransmitter release into membrane depolarization at excitatory synapses in the brain. The opening of the transmembrane ion channel of these ligand-gated receptors is driven by conformational transitions that are induced by the association of glutamate molecules to the ligand-binding domains (LBDs). Here, we describe the crystal structure of a GluA2 LBD tetramer in a configuration that involves an ∼30° rotation of the LBD dimers relative to the crystal structure of the full-length receptor. The configuration is stabilized by an engineered disulfide crosslink. Biochemical and electrophysiological studies on full-length receptors incorporating either this crosslink or an engineered metal bridge show that this LBD configuration corresponds to an intermediate state of receptor activation. GluA2 activation therefore involves a combination of both intra-LBD (cleft closure) and inter-LBD dimer conformational transitions. Overall, these results provide a comprehensive structural characterization of an iGluR intermediate state.
•The crystal structure of a GluA2 LBD tetramer captures an activation intermediate•Glutamate-binding domain dimers rotate by ?30° during activation•A disulfide bond between subunits traps a partially activated state•Trapping by engineered metal bridges confirms the conformational arrangement
Lau et al. show that an intermediate state in the activation pathway of AMPARs, a class of ionotropic glutamate receptors, involves an ∼30° rotation between the two ligand-binding domain dimers.</description><subject>Benzothiadiazines - pharmacology</subject><subject>Biophysical Phenomena - drug effects</subject><subject>Biophysical Phenomena - genetics</subject><subject>Cell Line, Transformed</subject><subject>Chemical bonds</subject><subject>Crystal structure</subject><subject>Crystallography, X-Ray - methods</subject><subject>Cysteine - genetics</subject><subject>Dithionitrobenzoic Acid - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Electric Stimulation</subject><subject>Excitatory Amino Acid Antagonists - pharmacology</subject><subject>Glutamic Acid - pharmacology</subject><subject>Humans</subject><subject>In Vitro Techniques</subject><subject>Ligands</subject><subject>Membrane Potentials - drug effects</subject><subject>Membrane Potentials - genetics</subject><subject>Models, Molecular</subject><subject>Molecular Conformation</subject><subject>Mutation</subject><subject>Mutation - genetics</subject><subject>Patch-Clamp Techniques</subject><subject>Phenanthrolines - pharmacology</subject><subject>Protein Structure, Tertiary - genetics</subject><subject>Proteins</subject><subject>Quinoxalines - pharmacology</subject><subject>Receptors, Glutamate - chemistry</subject><subject>Receptors, Glutamate - genetics</subject><subject>Receptors, Glutamate - metabolism</subject><subject>Uncoupling Agents - pharmacology</subject><issn>0896-6273</issn><issn>1097-4199</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU9r3DAQxUVJabZpv0EJhlx6sauRbFm-BJYlTQOBQmnPQpbHiRZb2kjyQr59tN00_XPoSQzzm6c38wj5ALQCCuLTtnK4BO8qRoFXVFSU8ldkBbRryxq67oSsqOxEKVjLT8nbGLeUQt108IacMt7xjMgVuVwXG-9GH2adrHd6Km5cwjDjYHXCwrrielqSng_FNzS4Sz4Ua5Ps_if_jrwe9RTx_fN7Rn58vvq--VLefr2-2axvS9OwOpWSDjD2g5CIrJNyaAzSXreiHUYwnDOUoI2RTI-5x3WvNfSge8N63vK-bvgZuTzq7pY-ezPoUtCT2gU76_CovLbq746z9-rO7xWXUDMmssDHZ4HgHxaMSc02Gpwm7dAvUUEjKBzuSjN68Q-69UvIp8mUyF5qWXOWqfpImeBjDDi-mAGqDkJqq44BqUNAigqVA8pj538u8jL0K5Hfm2I-595iUNFYdCYHEtAkNXj7_x-eAGMapQ8</recordid><startdate>20130807</startdate><enddate>20130807</enddate><creator>Lau, Albert Y.</creator><creator>Salazar, Héctor</creator><creator>Blachowicz, Lydia</creator><creator>Ghisi, Valentina</creator><creator>Plested, Andrew J.R.</creator><creator>Roux, Benoît</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>P64</scope><scope>RC3</scope><scope>5PM</scope></search><sort><creationdate>20130807</creationdate><title>A Conformational Intermediate in Glutamate Receptor Activation</title><author>Lau, Albert Y. ; Salazar, Héctor ; Blachowicz, Lydia ; Ghisi, Valentina ; Plested, Andrew J.R. ; Roux, Benoît</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c524t-80d1fbd68ee2988d5ce0ba767df1c332e81acc82af8d53abaa1b1abc2b373b453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Benzothiadiazines - pharmacology</topic><topic>Biophysical Phenomena - drug effects</topic><topic>Biophysical Phenomena - genetics</topic><topic>Cell Line, Transformed</topic><topic>Chemical bonds</topic><topic>Crystal structure</topic><topic>Crystallography, X-Ray - methods</topic><topic>Cysteine - genetics</topic><topic>Dithionitrobenzoic Acid - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Electric Stimulation</topic><topic>Excitatory Amino Acid Antagonists - pharmacology</topic><topic>Glutamic Acid - pharmacology</topic><topic>Humans</topic><topic>In Vitro Techniques</topic><topic>Ligands</topic><topic>Membrane Potentials - drug effects</topic><topic>Membrane Potentials - genetics</topic><topic>Models, Molecular</topic><topic>Molecular Conformation</topic><topic>Mutation</topic><topic>Mutation - genetics</topic><topic>Patch-Clamp Techniques</topic><topic>Phenanthrolines - pharmacology</topic><topic>Protein Structure, Tertiary - genetics</topic><topic>Proteins</topic><topic>Quinoxalines - pharmacology</topic><topic>Receptors, Glutamate - chemistry</topic><topic>Receptors, Glutamate - genetics</topic><topic>Receptors, Glutamate - metabolism</topic><topic>Uncoupling Agents - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lau, Albert Y.</creatorcontrib><creatorcontrib>Salazar, Héctor</creatorcontrib><creatorcontrib>Blachowicz, Lydia</creatorcontrib><creatorcontrib>Ghisi, Valentina</creatorcontrib><creatorcontrib>Plested, Andrew J.R.</creatorcontrib><creatorcontrib>Roux, Benoît</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neuron (Cambridge, Mass.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lau, Albert Y.</au><au>Salazar, Héctor</au><au>Blachowicz, Lydia</au><au>Ghisi, Valentina</au><au>Plested, Andrew J.R.</au><au>Roux, Benoît</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Conformational Intermediate in Glutamate Receptor Activation</atitle><jtitle>Neuron (Cambridge, Mass.)</jtitle><addtitle>Neuron</addtitle><date>2013-08-07</date><risdate>2013</risdate><volume>79</volume><issue>3</issue><spage>492</spage><epage>503</epage><pages>492-503</pages><issn>0896-6273</issn><eissn>1097-4199</eissn><abstract>Ionotropic glutamate receptors (iGluRs) transduce the chemical signal of neurotransmitter release into membrane depolarization at excitatory synapses in the brain. The opening of the transmembrane ion channel of these ligand-gated receptors is driven by conformational transitions that are induced by the association of glutamate molecules to the ligand-binding domains (LBDs). Here, we describe the crystal structure of a GluA2 LBD tetramer in a configuration that involves an ∼30° rotation of the LBD dimers relative to the crystal structure of the full-length receptor. The configuration is stabilized by an engineered disulfide crosslink. Biochemical and electrophysiological studies on full-length receptors incorporating either this crosslink or an engineered metal bridge show that this LBD configuration corresponds to an intermediate state of receptor activation. GluA2 activation therefore involves a combination of both intra-LBD (cleft closure) and inter-LBD dimer conformational transitions. Overall, these results provide a comprehensive structural characterization of an iGluR intermediate state.
•The crystal structure of a GluA2 LBD tetramer captures an activation intermediate•Glutamate-binding domain dimers rotate by ?30° during activation•A disulfide bond between subunits traps a partially activated state•Trapping by engineered metal bridges confirms the conformational arrangement
Lau et al. show that an intermediate state in the activation pathway of AMPARs, a class of ionotropic glutamate receptors, involves an ∼30° rotation between the two ligand-binding domain dimers.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>23931998</pmid><doi>10.1016/j.neuron.2013.06.003</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0896-6273 |
ispartof | Neuron (Cambridge, Mass.), 2013-08, Vol.79 (3), p.492-503 |
issn | 0896-6273 1097-4199 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3814226 |
source | MEDLINE; Cell Press Free Archives; Elsevier ScienceDirect Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Benzothiadiazines - pharmacology Biophysical Phenomena - drug effects Biophysical Phenomena - genetics Cell Line, Transformed Chemical bonds Crystal structure Crystallography, X-Ray - methods Cysteine - genetics Dithionitrobenzoic Acid - pharmacology Dose-Response Relationship, Drug Electric Stimulation Excitatory Amino Acid Antagonists - pharmacology Glutamic Acid - pharmacology Humans In Vitro Techniques Ligands Membrane Potentials - drug effects Membrane Potentials - genetics Models, Molecular Molecular Conformation Mutation Mutation - genetics Patch-Clamp Techniques Phenanthrolines - pharmacology Protein Structure, Tertiary - genetics Proteins Quinoxalines - pharmacology Receptors, Glutamate - chemistry Receptors, Glutamate - genetics Receptors, Glutamate - metabolism Uncoupling Agents - pharmacology |
title | A Conformational Intermediate in Glutamate Receptor Activation |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T15%3A34%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Conformational%20Intermediate%20in%20Glutamate%20Receptor%20Activation&rft.jtitle=Neuron%20(Cambridge,%20Mass.)&rft.au=Lau,%20Albert%C2%A0Y.&rft.date=2013-08-07&rft.volume=79&rft.issue=3&rft.spage=492&rft.epage=503&rft.pages=492-503&rft.issn=0896-6273&rft.eissn=1097-4199&rft_id=info:doi/10.1016/j.neuron.2013.06.003&rft_dat=%3Cproquest_pubme%3E1560110160%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1645348432&rft_id=info:pmid/23931998&rft_els_id=S0896627313004947&rfr_iscdi=true |